FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3119255813> ?p ?o ?g. }

• W3119255813 endingPage "119487" @default.
• W3119255813 startingPage "119487" @default.
• W3119255813 abstract "Optimized structure of azo compound NA4. • The azo compound was prepared by coupling reaction of dizonium salt of sulfanilamide with benzoylacetone. • We studied the nonlinear optical properties of azo compound. • The nonlinear refractive index of this sample is determined using diffraction ring patterns and Z-scan techniques. • The sample exhibits self-diffraction ring patterns due self-phase modulation. The dye of azo compound is prepared by coupling reaction of dizonium salt of sulfanilamide with benzoylacetone. The product is characterized by FTIR spectroscopy, Mass spectroscopy and 1 H NMR spectroscopy. The geometries of the synthesized dye is optimized using B3LYP method and 6-31G (d,p) basis sets. Nonlinear optical properties are investigated theoretically by calculation of some quantum chemical descriptors using the DFT/B3LYP method with a 6‐31G(d,p) basis set in comparison with urea as a standard. The UV–visible spectrum of synthesized azo dye are calculated using TD-DFT with B3LYP/6-31G(d,p) level. The nonlinear refractive index of the prepared dye is calculated via the diffraction ring patterns and Z-scan techniques using 473 nm visible, continuous wave laser light. The diffraction ring patterns are numerically simulated using the Fresnel-Kirchhoff theory with reasonable agreements. The property of optical limiting of the azo dye is tested." @default.
• W3119255813 created "2021-01-18" @default.
• W3119255813 creator A5022002344 @default.
• W3119255813 creator A5041260263 @default.
• W3119255813 creator A5070813702 @default.
• W3119255813 creator A5072101147 @default.
• W3119255813 creator A5080012602 @default.
• W3119255813 creator A5084029742 @default.
• W3119255813 date "2021-04-01" @default.
• W3119255813 modified "2023-10-16" @default.
• W3119255813 title "Synthesis, characterization and the nonlinear optical properties of newly synthesized 4-((1,3-dioxo-1-phenylbutan-2-yl)diazenyl)benzenesulfonamide" @default.
• W3119255813 cites W1237827684 @default.
• W3119255813 cites W1912125185 @default.
• W3119255813 cites W1965770515 @default.
• W3119255813 cites W1970238622 @default.
• W3119255813 cites W1976759198 @default.
• W3119255813 cites W1986105543 @default.
• W3119255813 cites W1989453019 @default.
• W3119255813 cites W1993212936 @default.
• W3119255813 cites W2018542681 @default.
• W3119255813 cites W2020742410 @default.
• W3119255813 cites W2035196917 @default.
• W3119255813 cites W2036241781 @default.
• W3119255813 cites W2040819188 @default.
• W3119255813 cites W2041431558 @default.
• W3119255813 cites W2044081357 @default.
• W3119255813 cites W2051586369 @default.
• W3119255813 cites W2059810336 @default.
• W3119255813 cites W2059926988 @default.
• W3119255813 cites W2060615019 @default.
• W3119255813 cites W2068173656 @default.
• W3119255813 cites W2079280642 @default.
• W3119255813 cites W2087344342 @default.
• W3119255813 cites W2088236896 @default.
• W3119255813 cites W2088563123 @default.
• W3119255813 cites W2098154447 @default.
• W3119255813 cites W2109756752 @default.
• W3119255813 cites W2113186299 @default.
• W3119255813 cites W2116421450 @default.
• W3119255813 cites W2328155468 @default.
• W3119255813 cites W2395839695 @default.
• W3119255813 cites W2599187009 @default.
• W3119255813 cites W2733466519 @default.
• W3119255813 cites W2749982566 @default.
• W3119255813 cites W2759559515 @default.
• W3119255813 cites W2770580871 @default.
• W3119255813 cites W2790126029 @default.
• W3119255813 cites W2802485313 @default.
• W3119255813 cites W2803501665 @default.
• W3119255813 cites W2890476114 @default.
• W3119255813 cites W2890878984 @default.
• W3119255813 cites W2913475840 @default.
• W3119255813 cites W2936840358 @default.
• W3119255813 cites W2947697062 @default.
• W3119255813 cites W2952636260 @default.
• W3119255813 cites W2972308736 @default.
• W3119255813 cites W2989076025 @default.
• W3119255813 cites W2990832090 @default.
• W3119255813 cites W2991228812 @default.
• W3119255813 cites W3002503619 @default.
• W3119255813 cites W3009620437 @default.
• W3119255813 cites W3019356415 @default.
• W3119255813 cites W3033867334 @default.
• W3119255813 cites W3036645670 @default.
• W3119255813 cites W3038585871 @default.
• W3119255813 cites W3066044615 @default.
• W3119255813 cites W3077070457 @default.
• W3119255813 cites W3111894326 @default.
• W3119255813 cites W332892299 @default.
• W3119255813 doi "https://doi.org/10.1016/j.saa.2021.119487" @default.
• W3119255813 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33503561" @default.
• W3119255813 hasPublicationYear "2021" @default.
• W3119255813 type Work @default.
• W3119255813 sameAs 3119255813 @default.
• W3119255813 citedByCount "30" @default.
• W3119255813 countsByYear W31192558132021 @default.
• W3119255813 countsByYear W31192558132022 @default.
• W3119255813 countsByYear W31192558132023 @default.
• W3119255813 crossrefType "journal-article" @default.
• W3119255813 hasAuthorship W3119255813A5022002344 @default.
• W3119255813 hasAuthorship W3119255813A5041260263 @default.
• W3119255813 hasAuthorship W3119255813A5070813702 @default.
• W3119255813 hasAuthorship W3119255813A5072101147 @default.
• W3119255813 hasAuthorship W3119255813A5080012602 @default.
• W3119255813 hasAuthorship W3119255813A5084029742 @default.
• W3119255813 hasConcept C113196181 @default.
• W3119255813 hasConcept C120665830 @default.
• W3119255813 hasConcept C121332964 @default.
• W3119255813 hasConcept C147597530 @default.
• W3119255813 hasConcept C147789679 @default.
• W3119255813 hasConcept C152365726 @default.
• W3119255813 hasConcept C160892712 @default.
• W3119255813 hasConcept C178790620 @default.
• W3119255813 hasConcept C185592680 @default.
• W3119255813 hasConcept C186490462 @default.
• W3119255813 hasConcept C188027245 @default.
• W3119255813 hasConcept C192562407 @default.
• W3119255813 hasConcept C207114421 @default.

• next